MRK Financial Facts

Less: Net Income Attributable to Noncontrolling Interests: 122.8M
Total Costs, Expenses and Other: 12.82B
See Full Income Statement

Stockholders' equity before deduction for treasury stock: 43.76B
Noncontrolling Interests: 2.41B
See Full Balance Sheet

Merck & Co. Inc. (MRK) Earnings

  |   Expand Research on MRK
Next EPS Date 4/29/21 EPS Growth Rate +9.3%
Average EPS % Beat Rate +15.3% Revenue Growth Rate +5.7%
Average % Move 1-Wk after EPS -3.1% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
4/29/21 Q121 N/A$1.64 N/A N/A$12.74B N/A N/A
2/4/21 Q420 $1.32$1.38 -$0.06$12.5B$12.68B Details
10/27/20 Q320 $1.74$1.43 +$0.31$12.6B$12.17B = Details
7/31/20 Q220 $1.37$1.04 +$0.33$10.9B$10.39B = Details
4/28/20 Q120 $1.50$1.34 +$0.16$12.06B$11.46B = Details
2/5/20 Q419 $1.16$1.15 +$0.01$11.9B$11.98B = Details
10/29/19 Q319 $1.51$1.24 +$0.27$12.4B$11.63B = Details
7/30/19 Q219 $1.30$1.16 +$0.14$11.8B$10.96B = Details